Czechia vs Hungary: Pharmaceutical consumption

Czechia
371.6 Defined daily dose per 1 000 inhabitants per day
in 2024
Hungary
442.3 Defined daily dose per 1 000 inhabitants per day
in 2025
Czechia rank
4th
Hungary rank
2nd

Pharmaceutical consumption over time

  • Czechia
  • Hungary
0100200300400198020022025

How they compare

Hungary currently reports 442.3 Defined daily dose per 1 000 inhabitants per day against 371.6 Defined daily dose per 1 000 inhabitants per day in Czechia, a difference of 70.7 Defined daily dose per 1 000 inhabitants per day.

That makes Hungary's figure about 1.2 times Czechia's.

The two have swapped places 2 times across 26 shared years of data; in 1999 it was Hungary ahead.

Czechia ranks 4th and Hungary ranks 2nd of 21 countries.

Across the 4 decades both report, Czechia averaged higher in 1 and Hungary in 3.

Head to head by decade

Decade Czechia Hungary Difference Ahead
1990s 221.5 Defined daily dose per 1 000 inhabitants per day 238.8 Defined daily dose per 1 000 inhabitants per day 17.3 Defined daily dose per 1 000 inhabitants per day Hungary
2000s 214.78 Defined daily dose per 1 000 inhabitants per day 228.1 Defined daily dose per 1 000 inhabitants per day 13.32 Defined daily dose per 1 000 inhabitants per day Hungary
2010s 270.85 Defined daily dose per 1 000 inhabitants per day 249.26 Defined daily dose per 1 000 inhabitants per day 21.59 Defined daily dose per 1 000 inhabitants per day Czechia
2020s 351.8 Defined daily dose per 1 000 inhabitants per day 399.24 Defined daily dose per 1 000 inhabitants per day 47.44 Defined daily dose per 1 000 inhabitants per day Hungary

Averages of every year both report within each decade.

Frequently asked questions

Which has higher pharmaceutical consumption, Czechia or Hungary?
Hungary, at 442.3 Defined daily dose per 1 000 inhabitants per day against 371.6 Defined daily dose per 1 000 inhabitants per day in Czechia as of 2025.
What is the difference in pharmaceutical consumption between Czechia and Hungary?
70.7 Defined daily dose per 1 000 inhabitants per day, with Hungary ahead.
How many years of comparable data are there for Czechia and Hungary?
26 years are reported by both, from 1999 to 2024.
How do Czechia and Hungary rank globally for pharmaceutical consumption?
Czechia ranks 4th and Hungary ranks 2nd of 21 countries.
Where does this data come from?
Organisation for Economic Co-operation and Development, published as Pharmaceutical consumption. Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Czechia vs Hungary: Pharmaceutical consumption. Statizoid, drawing on Organisation for Economic Co-operation and Development. Retrieved 20 August 2026, from https://health.statizoid.com/compare/pharmaceutical-consumption/czechia/hungary/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under OECD Terms and Conditions (attribution required); please keep the attribution.

<a href="https://health.statizoid.com/compare/pharmaceutical-consumption/czechia/hungary/">Czechia vs Hungary: Pharmaceutical consumption</a> — Statizoid

About this data

Indicator
Pharmaceutical consumption
Unit
Defined daily dose per 1 000 inhabitants per day
Source
Organisation for Economic Co-operation and Development
Licence
OECD Terms and Conditions (attribution required)
Coverage
31 places, 708 data points, 1980–2025
Last refreshed

Total pharmaceutical consumption according to the Anatomical Therapeutic Chemical (ATC) classification/Defined Daily Dose (DDD) system, created by the WHO Collaborating Centre for Drug Statistics Methodology. The unit of measurement is Defined Daily Dose (DDD), defined as the assumed average maintenance dose per day for a drug used on its main indication in adults. The Anatomical Therapeutic Chemical classification system divides drugs into different groups according to the organ system on which they act and/or therapeutical, pharmacological and chemical characteristics. The main principles for the classification of medicinal substances according to the ATC is presented in the publication “Guidelines for ATC classification and DDD assignment”, WHO Collaborating Centre for Drug Statistics Methodology, Oslo. The publication “ATC Index with DDDs” lists all assigned ATC codes and DDD values. Both these publications are updated annually. The ATC codes are based on the 2026 version of the ATC Index. All alterations implemented from January 2026 are available on the WHO Collaborating Centre for Drug Statistics Methodology website at https://www.whocc.no/lists_of__temporary_atc_ddds_and_alterations/. Data should reflect, where possible, the total consumption for each pharmaceutical drug category, i.e. including consumption in hospitals. Please refer to the Sources and Methods for detailed country-specific information.